Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
08/2010
08/31/2010US7785810 Detection of adhesion of cancer cells to a matrix coated with adhesion molecules; inhibiting the metastatic activity by administration of a dipeptidyl peptidase IV inhibitor.
08/31/2010US7785809 Nucleic acids and proteins of insect Or83b odorant receptor genes and uses thereof
08/31/2010US7785807 Voltage-gated, pH-sensitive anion channel and its novel splice variant involved in taste sensation
08/31/2010US7785804 Mammalian CX3C chemokine antibodies
08/31/2010US7785803 Antibody diagnostic kits and methods of use
08/31/2010US7785802 nucleic acid molecule coding for g protein-coupled recept for use in identifying modulators of taste transductance; artificial sweetners; used as additives in foods, beverages and medicinals for blocking bitter taste
08/31/2010US7785801 Identification of surface-associated antigens for tumor diagnosis and therapy
08/31/2010US7785797 detecting the gene expression level of a nucleic acid comprising measuring the RNA level expressed by polymerase chain reaction or by hybridization to an oligonucleotide comprising DNA, RNA, cDNA, peptide nucleic acids, genomic DNA or synthetic oligonucleotides
08/31/2010US7785796 sequence determination of an immobilized target polynucleotide comprising monitoring the sequential incorporation of nucleotides complementary to the immobilized target polynucleotide; the nucleotides have a base that is linked to a detectable label via a cleavable linker; detection of the labels
08/31/2010US7785794 Variant TLR4 nucleic acid and uses thereof
08/31/2010US7785792 screening for compounds that modulate the activity of chromatin modifying enzymes, comprising contacting the compound with a cell comprising a polynucleotide encoding fusion proteins comprising zinc finger proteins and chromatin modifying enzymes anddetermining the difference in gene expression
08/31/2010US7785791 Polypeptide variants with altered effector function
08/31/2010US7785781 performing a bioassay on a sample to determine the sequence of an allele of the P2X1 promoter gene, to determine the to likelihood of developing peripheral vascular disease, strokes and myocardial necrosis; screening for anticoagulants
08/31/2010US7785779 Generating vector comprising regulatory sequences associated with protein translation elongation factor TU (P EF-TU); improving exogenous gene expression
08/31/2010US7785778 Porcine polymorphisms and methods for detecting them
08/31/2010US7785776 Homogeneous real-time mutation scanning using denaturation/renaturation kinetics; restriction fragment length polymorphisms
08/31/2010US7785603 Polynucleotide comprising a first nucleic acid fragment which encodes at least 20 contiguous amino acids of an influenza virus polypeptide, wherein codons of nucleic acid fragment are optimized for expression in humans; enhancing immune response of vertebrate in need of protection against IV infection
08/31/2010US7785602 Vaccination of pigs against disease by administering a first recombinant porcine adenovirus vector stably expressing a heterologous nucleotide sequence encoding the antigenic determinant of the disease, preferably Hog Cholera Virus or Pseudorabies virus
08/31/2010US7785599 Albumin fusion proteins
08/31/2010US7785596 administering galectins to the brain of the vertebrates to intensify in vivo proliferation of subventricular zone astrocytes and neuron stem cells; treatment of neurodegenerative diseases, brain and nervous system disorders
08/31/2010US7785593 Antibody (11C7) anti nogo a and its pharmaceutical use
08/31/2010US7785586 Capable of binding with a wild type HBsAg antigen and with at least one, preferably at least two or more, mutated forms of the HBsAg antigen
08/31/2010CA2518861C Carboxylic acid reductase polypeptide, nucleotide sequence encoding same and methods of use
08/31/2010CA2480427C Novel potassium-dependent sodium-calcium exchanger
08/31/2010CA2336472C Negative-sense rna virus vector for nerve cell
08/31/2010CA2332817C Il-6 antagonist peptides
08/31/2010CA2323743C Urokinase plasminogen activator receptor as a target for diagnosis of metastases
08/31/2010CA2290886C Nucleic acid binding proteins
08/31/2010CA2281262C Anti-human medullasin monoclonal antibody, process for producing the same and immunoassay using the same
08/31/2010CA2262010C Hsv strain lacking functional icp27 and icp34.5 genes
08/31/2010CA2217871C Altered polypeptides with increased half-life
08/31/2010CA2190592C Detection and differentiation of mycobacterium tuberculosis complex bacteria by direct variant repeat oligotyping
08/31/2010CA2190371C Receptor for oncostatin m
08/26/2010WO2010096678A2 Recombinant viral vectors
08/26/2010WO2010096660A2 Compositions and methods for diagnosing prostate cancer based on detection of slc45a3-elk4 fusion transcript
08/26/2010WO2010096613A1 Blended refuge deployment via manipulation during hybrid seed production
08/26/2010WO2010096603A2 Cancer-targeting peptides and uses thereof in cancer therapy
08/26/2010WO2010096594A2 Method for identifying a subpopulation of mammalian cells with distinctive ribosome translation profiles
08/26/2010WO2010096510A2 Tempering of cellulosic biomass
08/26/2010WO2010096488A1 Method of reducing acetylation in plants to improve biofuel production
08/26/2010WO2010096470A2 Method for inhibiting neurodegeneration
08/26/2010WO2010096418A2 Antibody molecules having specificity for human ox40
08/26/2010WO2010096249A2 Solenopsis invicta virus
08/26/2010WO2010096227A1 Markers associated with soybean rust resistance and methods of use therefor
08/26/2010WO2010096201A2 Synthesis of ara-2'-o-methyl-nucleosides, corresponding phosphoramidites and oligonucleotides incorporating novel modifications for biological application in therapeutics, diagnostics, g- tetrad forming oligonucleotides and aptamers
08/26/2010WO2010096125A1 Methods and kits for treating disease by administering insulin-like growth factor binding protein-2
08/26/2010WO2010096117A2 Methods of treating psychosis and schizophrenia based on polymorphisms in the erbb4 gene
08/26/2010WO2010096112A1 System for modulating expression of hypothalmic brain-derived neurotrophic factor (bdnf)
08/26/2010WO2010095966A1 New strain of salmonella enterica s. typhimurium, its use and a method to obtain a therapeutic vaccine vector
08/26/2010WO2010095910A2 Polypeptide having function for delaying anthesis or suppressing growth, polynucleotide encoding the same, and use thereof
08/26/2010WO2010095909A2 Method for producing plants with improved or suppressed blue light recognition capabilities
08/26/2010WO2010095879A2 Sirna to be bound to transcripts of apoptosis-related genes, and compositions for treating cancer using same
08/26/2010WO2010095751A1 High-efficiency lactic acid manufacturing method using candida utilis
08/26/2010WO2010095750A1 Manufacturing method for substances from candida utilis that can use xylose as carbon source
08/26/2010WO2010095721A1 Fused monooxygenase and process for producing oxide using same
08/26/2010WO2010095684A1 Culture medium and method for inducing differentiation into adipocytes
08/26/2010WO2010095642A1 Process for producing useful substance
08/26/2010WO2010095600A1 Homolactic fermentation from pentose
08/26/2010WO2010095461A1 Novel monoclonal antibody, and use thereof
08/26/2010WO2010095455A1 Hypo-immunogenic streptavidin and use thereof
08/26/2010WO2010095428A1 Foxm1 peptides and vaccines containing the same
08/26/2010WO2010095422A1 Therapeutic agent for malignant tumor
08/26/2010WO2010095364A1 Jarid1b for target gene of cancer therapy and diagnosis
08/26/2010WO2010095138A1 Novel kinase-start gene conferring resistance to plant disease and transgenic plants comprising it
08/26/2010WO2010094900A1 Means for purifying a coagulation protein, and methods for implementing same
08/26/2010WO2010094828A1 Markers of hepatic encephalopathy
08/26/2010WO2010094825A1 Use of a nucleotide sequence that regulates flowering time, plants expressing same and production method thereof
08/26/2010WO2010094772A1 Synthesis of sequence-verified nucleic acids
08/26/2010WO2010094734A2 Methods for identifying and compounds useful for the diagnosis and treatment of diseases involving inflammation
08/26/2010WO2010094733A2 Methods for identifying and compounds useful for the diagnosis and treatment of diseases involving inflammation
08/26/2010WO2010094732A1 Methods for identifying and compounds useful for the diagnosis and treatment of diseases involving inflammation
08/26/2010WO2010094665A2 Compositions and methods for degrading lignocellulosic biomass
08/26/2010WO2010094499A1 Methods and compositions for diagnosis and treatment of cancer
08/26/2010WO2010094491A1 Means for inhibiting the expression of ang2
08/26/2010WO2010094465A1 Regulatory nucleic acid of a human proteinase 3 variant
08/26/2010WO2010094288A1 Expressivity tag and use thereof
08/26/2010WO2010080032A3 Bead-assisted viral transduction
08/26/2010WO2010074859A3 Yeast-based methods of identifying nucleic acids and compounds for treating neurodegenerative diseases
08/26/2010WO2010073104A3 Improving cognitive function
08/26/2010WO2010072765A3 Mutant penicillin g acylases
08/26/2010WO2010070086A3 Method for the enzymatic reaction of alkanes
08/26/2010WO2010062779A3 Modified dna polymerases
08/26/2010WO2010062777A3 Modified type a dna polymerases
08/26/2010WO2010057152A3 Cross-species chimeric rna molecules
08/26/2010WO2010055292A3 Baculoviral vectors
08/26/2010WO2010049807A3 T7 dual promoter-based vector system for recombinant expression of polypeptides
08/26/2010WO2010048317A3 Micro-rnas as markers for tumor progression
08/26/2010WO2010047835A3 Double-stranded ribonucleic acids with rugged physico-chemical structure and highly specific biologic activity
08/26/2010WO2010045617A9 Detecting genetic abnormalities
08/26/2010WO2010045002A3 Gene therapy vectors and cytosine deaminases
08/26/2010WO2010040571A4 Method for a genome wide identification of expression regulatory sequences and use of genes and molecules derived thereof for the diagnosis and therapy of metabolic and/or tumorous diseases
08/26/2010WO2010040134A3 Independently inducible system of gene expression
08/26/2010WO2010034758A3 dsRNA FOR TREATING VIRAL INFECTION
08/26/2010WO2010033920A3 Compositions and methods for enhancing cell reprogramming
08/26/2010WO2010027828A3 Pd-1 antagonists and methods of use thereof
08/26/2010WO2010009348A8 Transformation of glycerol and cellulosic materials into high energy fuels
08/26/2010WO2010005704A3 Novel helper plasmid, defective sindbis viral vectors and methods of use thereof
08/26/2010WO2010003614A3 Transfection solution
08/26/2010WO2009136293A3 Genes and methods for increasing disease resistance in plants
08/26/2010WO2009101126A9 Method for producing sclareol
1 ... 960 961 962 963 964 965 966 967 968 969 970 971 972 973 974 975 976 977 978 979 980 ... 4023